KDM4B-IN-B3 Size:Contact [email protected] for quotation Through its simultaneous HDAC inhibitory

Through its simultaneous HDAC inhibitory activity

Merck has stopped its phase III clinical trials with the drugs due to high level of central side effects

RGFP966 (3 or 10 mg/kg

Chemical Name: N-{4-chloro-3-[6-(dimethylamino)-1H-1

KDM4B-IN-B3 Size:Contact [email protected] for quotation Through its simultaneous HDAC inhibitoryKDM4B IN B3, also know as NCGC00244536, is a novel KDM4 inhibitor. KDM4B IN B3 inhibits the in vivo growth of tumors derived from PC3 cells and ex vivo human PCa explants. Histone lysine demethylase KDM4 JMJD2s are overexpressed in many human tumors including prostate cancer (PCa). Product information CAS Number: 2003260 55 5 Molecular Weight: 382. 45 Formula: C25H22N2O2 Synonym: NCGC00244536 Chemical Name: 3 (8 Hydroxyquinolin 6 yl) N (3